Top Clinical Trials companies in Canada by Cash and Short-Term Investments

This ranking features the top 15 Clinical Trials companies in Canada ranked by Cash and Short-Term Investments, totaling a Cash and Short-Term Investments of USD 2.62 B, for February 07, 2025.
#
Name
Cash and Short-Term Investments
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 760.59 M
Dec. 31, 2023 USD 3.17 -1.86%

Canada

2
USD 638.08 M
Dec. 31, 2023 USD 39.98 -1.21%

Canada

3
USD 374.33 M
Dec. 31, 2023 USD 14.60 -0.95%

Canada

4
USD 350.49 M
Dec. 31, 2023 USD 7.95 -0.62%

Canada

5
USD 223.63 M
Dec. 31, 2023 USD 1.22 2.52%

Canada

6
USD 116.51 M
Dec. 31, 2023 USD 4.00 3.39%

Canada

7
USD 40.85 M
Nov. 30, 2023 USD 1.52 2.02%

Canada

8
USD 39.83 M
Dec. 31, 2023 USD 9.51 -0.80%

Canada

9
USD 26.21 M
Dec. 31, 2023 USD 6.23 -0.19%

Canada

10
USD 21.95 M
Dec. 31, 2023 USD 2.96 1.10%

Canada

11
USD 6.61 M
June 30, 2024 USD 3.15 0.64%

Canada

12
USD 6.56 M
Aug. 31, 2024 USD 1.86 5.08%

Canada

13
USD 5.36 M
Sept. 30, 2023 USD 1.91 1.06%

Canada

14
USD 5.25 M
March 31, 2024 USD 2.65 -1.93%

Canada

15
USD 3.45 M
Dec. 31, 2023 USD 0.89 -2.92%

Canada

Frequently Asked Questions
  • Which Clinical Trials company in Canada has the highest Cash and Short-Term Investments ?

    The Clinical Trials company in Canada with the highest Cash and Short-Term Investments is AbCellera Biologics Inc. (NasdaqGS: ABCL) at USD 760.59 M.

  • Which Clinical Trials company in Canada has the lowest Cash and Short-Term Investments ?

    The Clinical Trials company in Canada with the lowest Cash and Short-Term Investments is XORTX Therapeutics Inc. (TSXV: XRTX.V) at USD 3.45 M.

SV Wall Street